Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging
- PMID: 8805740
- DOI: 10.1016/s1071-3581(96)90034-3
Comparison between dipyridamole and adenosine as pharmacologic coronary vasodilators in detection of coronary artery disease with thallium 201 imaging
Abstract
Background: Both dipyridamole and adenosine are widely used as pharmacologic stressors with 201Tl imaging for detection of coronary artery disease. The purpose of this study was to compare dipyridamole and adenosine 201Tl imaging directly in patients with angiographically proved coronary artery disease.
Methods and results: Fifty-four patients were submitted to two planar 201Tl studies: one with dipyridamole and the other with adenosine. The interval between the two studies varied from 2 to 7 days and the order was assigned randomly. Three standard planar views were obtained 10 minutes and 4 hours after the injection of 3.0 mCi 201Tl. Administration of dipyridamole was as follows: 0.142 mg/kg/min during 4 minutes, followed by a slight exercise and 201Tl injection. The infusion of adenosine was as follows: 0.140 mg/kg/min during 6 minutes with injection of 201Tl after the third minute of infusion. Patients were asked to give their preference considering the number, type, severity, and duration of side effects on a scale from 0 (worst) to 5 (best). Reading was done by two experienced observers. The heart was divided into three segments per view. The change in systolic blood pressure was -12 +/- 11 mm Hg for adenosine and -5 +/- 10 mm Hg for dipyridamole (p < 0.001), and the change in heart rate was 18 +/- 10 beats/min for adenosine and 8 +/- 7 beats/min for dipyridamole (p < 0.001). With regions of interest, ischemic/normal wall ratios were determined: 0.78 +/- 0.06 for adenosine and 0.83 +/- 0.08 for dipyridamole (p < 0.001). Adenosine detected 295 normal, 170 ischemic, and 21 scar segments, whereas dipyridamole detected 326, 135, and 25 segments, respectively. Patients preferred adenosine (4.3 +/- 1.0 for adenosine vs 3.8 +/- 1.5 for dipyridamole; p < 0.04) mainly because of the short duration of side effects.
Conclusion: This study shows that the use of adenosine with 201Tl imaging may have some advantages over dipyridamole.
Comment in
-
Are the differences between adenosine and dipyridamole clinically relevant?J Nucl Cardiol. 1996 May-Jun;3(3):281-3. doi: 10.1016/s1071-3581(96)90042-2. J Nucl Cardiol. 1996. PMID: 8805748 No abstract available.
Similar articles
-
Thallium-201 myocardial imaging in patients with coronary artery disease: comparison of intravenous adenosine and oral dipyridamole.Ann Pharmacother. 1992 Nov;26(11):1352-7. doi: 10.1177/106002809202601102. Ann Pharmacother. 1992. PMID: 1477436 Clinical Trial.
-
Thallium-201-dipyridamole imaging: comparison between a standard dose and a high dose of dipyridamole in the detection of coronary artery disease.J Nucl Med. 1994 Aug;35(8):1245-53. J Nucl Med. 1994. PMID: 8046475 Clinical Trial.
-
Comparison between technetium-99m-teboroxime and thallium-201 dipyridamole planar myocardial perfusion imaging in detection of coronary artery disease.Am J Cardiol. 1992 Jan 1;69(1):90-6. doi: 10.1016/0002-9149(92)90681-n. Am J Cardiol. 1992. PMID: 1729873
-
Radionuclide methods of identifying patients who may require coronary artery bypass surgery.Circulation. 1985 Dec;72(6 Pt 2):V9-22. Circulation. 1985. PMID: 3905063 Review.
-
Intravenous dipyridamole: use in thallous chloride TL 201 stress imaging.DICP. 1991 Oct;25(10):1085-91. doi: 10.1177/106002809102501013. DICP. 1991. PMID: 1803798 Review.
Cited by
-
Comparison of exercise, dipyridamole, adenosine, and dobutamine stress with the use of Tc-99m tetrofosmin tomographic imaging.J Nucl Cardiol. 1999 Jul-Aug;6(4):389-96. doi: 10.1016/s1071-3581(99)90004-1. J Nucl Cardiol. 1999. PMID: 10461605 Clinical Trial.
-
Patient Selection and Clinical Indication for Chronic Total Occlusion Revascularization-A Workflow Focusing on Non-Invasive Cardiac Imaging.Life (Basel). 2022 Dec 20;13(1):4. doi: 10.3390/life13010004. Life (Basel). 2022. PMID: 36675954 Free PMC article. Review.
-
Are the differences between adenosine and dipyridamole clinically relevant?J Nucl Cardiol. 1996 May-Jun;3(3):281-3. doi: 10.1016/s1071-3581(96)90042-2. J Nucl Cardiol. 1996. PMID: 8805748 No abstract available.
-
Comparison of pharmacologic stress agents.J Nucl Cardiol. 1996 Nov-Dec;3(6 Pt 2):S22-6. doi: 10.1016/s1071-3581(96)90204-4. J Nucl Cardiol. 1996. PMID: 8989683 Review.
-
Coronary microvascular dysfunction in autoimmune rheumatic diseases: beyond coronary flow velocity reserve.Front Cardiovasc Med. 2024 Aug 21;11:1372703. doi: 10.3389/fcvm.2024.1372703. eCollection 2024. Front Cardiovasc Med. 2024. PMID: 39234606 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources